Guidance
Evidence-based recommendations on maximal cytoreductive surgery for advanced ovarian cancer. This involves removing all or almost all visible cancerous tissue. More tissue is removed than with standard surgery. The aim is to improve outcomes for people with advanced ovarian cancer.
Is this guidance up to date?
Next review: this guidance will be reviewed if there is new evidence or safety concerns.
Guidance development process
How we develop NICE interventional procedures guidance
This guidance replaces NICE interventional procedures guidance on ultra-radical (extensive) surgery for advanced ovarian cancer (IPG470).